NLRC5_ICTPU
ID NLRC5_ICTPU Reviewed; 1726 AA.
AC C6FG12;
DT 05-OCT-2010, integrated into UniProtKB/Swiss-Prot.
DT 01-SEP-2009, sequence version 1.
DT 03-AUG-2022, entry version 37.
DE RecName: Full=Protein NLRC5;
GN Name=nlrc5;
OS Ictalurus punctatus (Channel catfish) (Silurus punctatus).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Siluriformes;
OC Ictaluridae; Ictalurus.
OX NCBI_TaxID=7998;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX PubMed=19414032; DOI=10.1016/j.dci.2009.04.004;
RA Sha Z., Abernathy J.W., Wang S., Li P., Kucuktas H., Liu H., Peatman E.,
RA Liu Z.;
RT "NOD-like subfamily of the nucleotide-binding domain and leucine-rich
RT repeat containing family receptors and their expression in channel
RT catfish.";
RL Dev. Comp. Immunol. 33:991-999(2009).
CC -!- FUNCTION: Probable regulator of the NF-kappa-B and type I interferon
CC signaling pathways. May also regulate the type II interferon signaling
CC pathway. Plays a role in homeostatic control of innate immunity and in
CC antiviral defense mechanisms (By similarity). {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the NLRP family. {ECO:0000305}.
CC -!- CAUTION: Supposed to contain a CARD domain at the N-terminus. However,
CC this domain is not detected by Pfam, PROSITE or SMART. Has a weak
CC similarity with a DAPIN domain. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; FJ004847; ACM45227.1; -; mRNA.
DR RefSeq; NP_001186995.1; NM_001200066.1.
DR AlphaFoldDB; C6FG12; -.
DR SMR; C6FG12; -.
DR STRING; 7998.ENSIPUP00000029542; -.
DR GeneID; 100303710; -.
DR KEGG; ipu:100303710; -.
DR CTD; 84166; -.
DR OrthoDB; 19417at2759; -.
DR Proteomes; UP000221080; Chromosome 4.
DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR Gene3D; 3.40.50.300; -; 1.
DR Gene3D; 3.80.10.10; -; 8.
DR InterPro; IPR001611; Leu-rich_rpt.
DR InterPro; IPR006553; Leu-rich_rpt_Cys-con_subtyp.
DR InterPro; IPR032675; LRR_dom_sf.
DR InterPro; IPR007111; NACHT_NTPase.
DR InterPro; IPR041267; NLRP_HD2.
DR InterPro; IPR027417; P-loop_NTPase.
DR Pfam; PF13516; LRR_6; 4.
DR Pfam; PF05729; NACHT; 1.
DR Pfam; PF17776; NLRC4_HD2; 1.
DR SMART; SM00367; LRR_CC; 6.
DR SUPFAM; SSF52540; SSF52540; 1.
DR PROSITE; PS50837; NACHT; 1.
PE 2: Evidence at transcript level;
KW ATP-binding; Cytoplasm; Immunity; Innate immunity; Leucine-rich repeat;
KW Nucleotide-binding; Repeat.
FT CHAIN 1..1726
FT /note="Protein NLRC5"
FT /id="PRO_0000397876"
FT DOMAIN 207..537
FT /note="NACHT"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00136"
FT REPEAT 879..902
FT /note="LRR 1"
FT REPEAT 904..925
FT /note="LRR 2"
FT REPEAT 1002..1025
FT /note="LRR 3"
FT REPEAT 1026..1048
FT /note="LRR 4"
FT REPEAT 1103..1126
FT /note="LRR 5"
FT REPEAT 1128..1155
FT /note="LRR 6"
FT REPEAT 1212..1235
FT /note="LRR 7"
FT REPEAT 1351..1374
FT /note="LRR 8"
FT REPEAT 1387..1411
FT /note="LRR 9"
FT REPEAT 1421..1443
FT /note="LRR 10"
FT REPEAT 1447..1468
FT /note="LRR 11"
FT REPEAT 1502..1525
FT /note="LRR 12"
FT REPEAT 1532..1553
FT /note="LRR 13"
FT REPEAT 1560..1580
FT /note="LRR 14"
FT REPEAT 1588..1609
FT /note="LRR 15"
FT REPEAT 1616..1637
FT /note="LRR 16"
FT REPEAT 1642..1662
FT /note="LRR 17"
FT REPEAT 1670..1691
FT /note="LRR 18"
FT BINDING 213..220
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00136"
SQ SEQUENCE 1726 AA; 192891 MW; 56AC36A437CDDD8B CRC64;
MKMEEMDLEE DVLDVVDQEA STIVDILCEQ RDNVLQRIFA LVDARTREQL QHLPNNRESI
SGLVDYFRTS DQHTCRRFLD IIWSFCENIP LELDIRIVNL AGSTAGALVN NSHVPDTENS
PQSRYGKRAR LDQVQSYTNA VKSFLQKKFE KVTKDIKKEV CLNNTWLCWR TQKYARVRDR
PAKSQEGEEV SLEHKESVEA LLMKTGRVVM LSGQAGSGKT LLMHCLAHHW AQGSYPSIEL
LFLLEFRQLN LISQPLSLKE LLFRFFLPSD EDDEQSEAVL NYVLSNPEKI CFIFDGYDEF
GARFKDPKEL ECSVNPYQQL PLADLLSALC SAKILPGCTV LVTCRPRDVF DLFGSSDYFV
AELLGFNQQR VKEYTQEYFQ EKGCEIKERA VSLLMDSHHL LSMSHVPGLC HVCCVCLDHF
LTSDMSQQPG TQLPTSLTQI YLHILSAFIS RCHGCGSSDN HTPLLQRYRV QIAMLSKLAM
DGLENSRIVF PANELTTELM NFGANAGILS RLDLTCGDGS RRLGCAFTHL TIQEFMAALH
LMTNPDITES QLKKKLNLKS RWTAKTDPKT VFTDSLHLYM CGLAAEACTS NLVLLKGSEN
ARAIVLKRQD AVLKTLQRFV VSGRQTGPKI IELCRCAHET QNIDLARAIG PRDRFELRNI
RLNPVDIDAL AFVISSANQM VCLDFGACYI EPECLNIIPN CKNLEELNFR SRKYDDKFAE
ALSGILPKLQ SLKQLHFISG GLTNIGAAKL FKASECCPQI TRLNVSDNYL TDESVKKITE
LFPKLAKLTS VILGKNNISI NGIFILAGKM AAFPNIKEVY ANAKKKEINV QFSANTTNSA
STDDLNNTEE SKQLILNDWN LKWTNVHNLC PMLRGCSSLT VLNLSHNALG NRGLKKLLEH
LPTLDTIQEI NVSDNGVDMD GVVLLSPLLC TLKDLTEVEA SHNGKKMLVL TFSSSIIDAL
KQVTSEGCDI LHKKLSLTHS DIHPTDMNKL CKNLIKCPNP LNLDFSHGTL KDESTEKLLK
FLPNMASLNL LNLSHIQMST DSALLLVQLL SDCQRTTTVE LRQLGETFIK FLQDKSEAAT
CKFNQYRLSS ANLAKLCEIL EHCHHLTDLD LSSNFLKDED VKTFVQFLPK LQISGSVSLN
NNNLTEVGVL YLLSLMHTCE RVAAVEVSLG KEEQQDIIGF VQKNCTGKTF RLSSCTVQSQ
NVLFLLNKLA TLNSVQTLEL RNNSFSADTI KYLITEFCGD CNHRTIRIME PWIKGEAAVG
LVQCCLELNP NIKEIRVEKT CLKLSVESLV SATIPNEWEN GNCSLSAVHC ISFDDCEVEG
QHLSSLQSAL RNCPSLQELH FSQLTMGADG AEFLSSVLPS LKNLKILSLS SKGETEDEAV
IFALQHAQKH LEQLSLAHHV IKDRGAAVLG NALQGFTRMR SLSLLKCLDW TATGGRDLVR
GLVQCHSLEE IRLDSIELDE ESIDCFAQGL QAMTSLKKIS LNKTISKEGS GVLCLLASLH
PLIELEEIEL IGLRMGDRGV EELVKHIPKW TRLRKINLSE NRVSDHAGEM LVKALSHCRA
LQQIHLFRNN LGHSSAAVLG QVLPSLSELT ELDLSENQME SKGCSSVCEA LVSMKALKKL
HLTSIGTSDL VNVASCLKHC TSIEDISLSW NNCENDVVLK LAEVLPQCSK LKRLDLEANN
INTSGAMALA TCLQFCPWIE VIRLWRNPIK KDDLILKDKR LNFSST